TipRanks
JCR Pharmaceuticals Co., Ltd. (JP:4552)
:4552
Japanese Market
4552
JCR Pharmaceuticals Co., Ltd.
RESEARCH TOOLSreports
Want to see JP:4552 full AI Analyst Report?

JCR Pharmaceuticals Co., Ltd. (4552) Ratios

1 Followers

JCR Pharmaceuticals Co., Ltd. Ratios

JP:4552's free cash flow for Q2 2026 was ¥0.84. For the 2026 fiscal year, JP:4552's free cash flow was decreased by ¥ and operating cash flow was ¥0.26. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 26Mar 25Mar 24
Liquidity Ratios
Current Ratio
 ― 1.16 1.16 1.91 1.34
Quick Ratio
 ― 0.67 0.67 1.22 0.82
Cash Ratio
 ― 0.30 0.29 0.62 0.37
Solvency Ratio
 ― -0.02 0.08 0.19 0.14
Operating Cash Flow Ratio
 ― -0.12 >-0.01 0.31 -0.15
Short-Term Operating Cash Flow Coverage
 ― -0.21 >-0.01 1.04 -0.32
Net Current Asset Value
¥ ―¥ -6.96B¥ -5.80B¥ 11.83B¥ 5.28B
Leverage Ratios
Debt-to-Assets Ratio
 ― 0.36 0.49 0.23 0.24
Debt-to-Equity Ratio
 ― 0.81 1.15 0.41 0.44
Debt-to-Capital Ratio
 ― 0.45 0.53 0.29 0.30
Long-Term Debt-to-Capital Ratio
 ― 0.20 0.21 0.20 0.10
Financial Leverage Ratio
 ― 2.24 2.33 1.82 1.82
Debt Service Coverage Ratio
 ― -0.04 0.12 0.98 0.34
Interest Coverage Ratio
 ― -44.14 1.08 87.58 113.07
Debt to Market Cap
 ― 0.64 0.78 0.22 0.13
Interest Debt Per Share
 ― 310.44 445.21 187.40 183.77
Net Debt to EBITDA
 ― -8.70 6.45 0.43 1.28
Profitability Margins
Gross Profit Margin
―65.15%74.56%72.90%74.13%
EBIT Margin
―-18.93%8.98%17.10%15.89%
EBITDA Margin
―-8.72%15.33%24.56%21.70%
Operating Profit Margin
―-20.69%1.07%17.57%14.49%
Pretax Profit Margin
―-19.39%8.00%16.90%15.76%
Net Profit Margin
―-14.39%5.40%12.85%10.98%
Continuous Operations Profit Margin
―-14.20%5.47%12.92%11.03%
Net Income Per EBT
―74.18%67.59%76.02%69.70%
EBT Per EBIT
―93.76%748.03%96.18%108.78%
Return on Assets (ROA)
―-4.51%1.99%5.39%3.97%
Return on Equity (ROE)
―-10.11%4.64%9.80%7.23%
Return on Capital Employed (ROCE)
―-11.13%0.71%10.45%8.41%
Return on Invested Capital (ROIC)
―-5.72%0.29%7.11%4.55%
Return on Tangible Assets
―-4.64%2.04%5.58%4.13%
Earnings Yield
―-7.94%3.15%5.25%2.15%
Efficiency Ratios
Receivables Turnover
 ― 2.70 2.85 2.87 3.08
Payables Turnover
 ― 19.53 19.62 13.06 5.69
Inventory Turnover
 ― 0.53 0.43 0.56 0.48
Fixed Asset Turnover
 ― 0.88 1.03 1.43 1.05
Asset Turnover
 ― 0.31 0.37 0.42 0.36
Working Capital Turnover Ratio
 ― 1.92 5.37 2.17 2.13
Cash Conversion Cycle
 ― 805.50 964.94 756.72 814.64
Days of Sales Outstanding
 ― 135.04 128.21 127.15 118.36
Days of Inventory Outstanding
 ― 689.14 855.34 657.53 760.48
Days of Payables Outstanding
 ― 18.69 18.61 27.96 64.20
Operating Cycle
 ― 824.18 983.55 784.68 878.84
Cash Flow Ratios
Operating Cash Flow Per Share
 ― -44.30 -1.11 74.62 -44.25
Free Cash Flow Per Share
 ― -124.16 -94.82 57.83 -113.11
CapEx Per Share
 ― 79.85 93.71 16.79 68.86
Free Cash Flow to Operating Cash Flow
 ― 2.80 85.64 0.78 2.56
Dividend Paid and CapEx Coverage Ratio
 ― -0.44 >-0.01 2.03 -0.49
Capital Expenditure Coverage Ratio
 ― -0.55 -0.01 4.44 -0.64
Operating Cash Flow Coverage Ratio
 ― -0.14 >-0.01 0.40 -0.24
Operating Cash Flow to Sales Ratio
 ― -0.17 >-0.01 0.22 -0.16
Free Cash Flow Yield
―-25.65%-16.69%6.88%-8.00%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 ― -12.59 31.80 19.03 46.57
Price-to-Sales (P/S) Ratio
 ― 1.81 1.72 2.45 5.11
Price-to-Book (P/B) Ratio
 ― 1.27 1.48 1.87 3.37
Price-to-Free Cash Flow (P/FCF) Ratio
 ― -3.90 -5.99 14.52 -12.49
Price-to-Operating Cash Flow Ratio
 ― -10.92 -513.06 11.26 -31.94
Price-to-Earnings Growth (PEG) Ratio
 ― 0.07 -0.22 0.42 -0.63
Price-to-Fair Value
 ― 1.27 1.48 1.87 3.37
Enterprise Value Multiple
 ― -29.47 17.66 10.39 24.84
Enterprise Value
 ― 85.02B 109.15B 109.37B 185.17B
EV to EBITDA
 ― -29.47 17.66 10.39 24.84
EV to Sales
 ― 2.57 2.71 2.55 5.39
EV to Free Cash Flow
 ― -5.53 -9.44 15.15 -13.17
EV to Operating Cash Flow
 ― -15.50 -808.50 11.74 -33.67
Tangible Book Value Per Share
 ― 359.19 367.10 424.54 392.25
Shareholders’ Equity Per Share
 ― 379.91 384.95 450.18 419.61
Tax and Other Ratios
Effective Tax Rate
 ― 0.27 0.32 0.24 0.30
Revenue Per Share
 ― 267.09 330.64 343.54 276.27
Net Income Per Share
 ― -38.43 17.87 44.13 30.34
Tax Burden
 ― 0.74 0.68 0.76 0.70
Interest Burden
 ― 1.02 0.89 0.99 0.99
Research & Development to Revenue
 ― 0.47 0.42 0.26 0.26
SG&A to Revenue
 ― 0.39 0.32 0.00 0.00
Stock-Based Compensation to Revenue
 ― 0.00 0.00 <0.01 <0.01
Income Quality
 ― 1.15 -0.06 1.69 -1.02
Currency in JPY